FDA shakes up top lead­er­ship around gener­ic drugs

Pa­trizia Cavaz­zoni, head of the FDA’s drug cen­ter, an­nounced via email to staff to­day that Iilun Mur­phy will take over as per­ma­nent di­rec­tor of the Of­fice of Gener­ic Drugs (OGD), re­plac­ing Su­san Rosen­crance, who has served as act­ing OGD di­rec­tor since Oc­to­ber.

But OGD is al­so get­ting a clos­er look from the very top of FDA as re­cent gener­ic can­cer drug short­ages have led to new im­ports from Chi­na, in ad­di­tion to new safe­ty ques­tions re­lat­ed to the US mil­i­tary re-test­ing gener­ics (see this Bloomberg sto­ry yes­ter­day).

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.